Activity Overview
Activity Overview
The 2024 RISE Performance Improvement activity is an online performance improvement activity by which evidence-based performance measures and quality improvement interventions/changes are used to help providers identify patient care areas for improvement and positively change their performance.
Current RISE registry users will be able to assess their current Quality measure performance in their 2024 RISE dashboard, select measures in which they would like to improve their performance, implement changes within their practice for 90 consecutive days to improve measure performance, and re-assess their measure performance to see if and how their performance changed.
Target Audience
This course is designed for rheumatologists, physicians, and other health care providers who care for patients with rheumatic diseases and those interested or engaged in research in the field of rheumatology.
Learning Objectives
Upon completion of this activity, participants should be able to do the following:
- Assess their performance on Quality measures and identify which measures need performance improvement
- Identify and implement change(s) in their practice to improve their Quality measure performance
- Assess their Quality measure performance after implementing the change(s) and summarize the outcome that resulted from implementing the change(s)
CME & MOC Information
CME
Accreditation Statement
The American College of
Rheumatology is accredited by the Accreditation Council for Continuing Medical
Education (ACCME) to provide continuing medical education for physicians.Designation Statement
The American College of Rheumatology designates this performance improvement activity for a maximum of 20 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME credit must be claimed by December 31, 2024 at 11:59 PM ET.
MOC
MOC Recognition Statement
American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 20.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
MOC points must be claimed by December 31, 2024 at 11:59 PM ET.
By completing this activity, you provide the ACR permission to
share completion data with the ACCME and the certifying board.
Faculty and Disclosures
ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Accredited Continuing Education (ACE) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.
For this educational activity, all conflicts of interest have been mitigated through peer review and revisions to ensure independence, evidence based, fair balance, and absence of commercial bias.
Nature of Financial Relationships
Faculty participating in an ACR-sponsored activity must disclose to the planning committee and audience all financial relationships with ineligible companies and the nature of financial or other relationship(s) with an ineligible company including, but not limited to:- Advisor or review panel member
- Consultant
- Employee
- Officer or Board Member
- Grant/research support
- Speaker/honoraria, includes speakers' bureau, symposia, and expert witness
- Independent contractor
- Ownership interest
- Royalties
- Intellectual property/patents
- Stock options or bond holdings in a for-profit corporation or self-directed pension plan
None: Has no relevant financial relationship(s) with ineligible companies to disclose.
2024 RISE Performance Improvement Activity Planning Committee Disclosures
Danette Ko, MD - No relevant financial relationships to disclose (activity reviewer)
Meera Subash, MD – Consultant for Rheumera, LLC (activity planner)
Lindsey Ottaviano, MS - No relevant financial relationships to disclose (activity planner)
*All of the relevant financial relationships listed for these individuals have been mitigated.